Arkolith/Insider Trading/ENZN/Form 4

Xstelos Corp.

10% OwnerENZON PHARMACEUTICALS, INC. (ENZN) · full profile →Form 4 · filed Aug 17, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$42K
Net Open-Market Flow
-$42K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2021Sell(S)58K$0.39$22K2.0M
Aug 13, 2021Sell(S)50K$0.39$20K350K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-21-002138) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML